Jnana Therapeutics

About:

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Twitter/X: jnanatx

Top Investors: AbbVie, RA Capital Management, Polaris Partners, Versant Ventures, Bain Capital Life Sciences

Description:

Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. Utilizing its RAPID platform, the firm accelerates the identification of therapeutic targets and the creation of small molecule therapies for various diseases. Jnana aims to enhance drug discovery efficiency through advanced chemoproteomics techniques, addressing unmet medical needs.

Total Funding Amount:

$207M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)jnanatx.com

Founders:

Amir Nashat, Joanne Kotz, Joel Barrish, John Throup

Number of Employees:

51-100

Last Funding Date:

2022-11-15

IPO Status:

Private

Industries: